Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anterior QLB for Analgesia in Laparoscopic Colorectal Surgery
NCT06653439Completed
- Sponsor
- Ondokuz Mayıs University
- Start
- Oct 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Cumulative opioid consumption in the first 24 hours after surgery. Started Oct 2024; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06653439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653439.